Product Images Dalfampridine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Dalfampridine NDC 65862-863 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - dalfampridine fig1
This is a description of the results obtained from study/trial number 1, in which the average change in walking speed was measured during a double-blind phase. The data is presented in Figure 1 as a graph that shows the average percent increase in walking speed from baseline. The placebo group, consisting of 72 participants, is represented by the "0%" bar. The "D st tables 10 mg b.id" group, consisting of 224 participants, is represented by the "%" bars ranging from 20-60%.*
Figure 2 - dalfampridine fig2
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (60 Tablets Bottle) - dalfampridine fig3
This is a medication named Dalfampridine, available in extended-release tablets of 10 mg each. The tablets are film-coated and should not be divided, crushed, chewed or dissolved. The dispenser is required to provide a medication guide to each patient separately. The manufacturer is Aurobindo Pharma USA, Inc. Each package contains 60 tablets and should be stored in a container with a child-resistant closure at a temperature of 20° to 25°C (68° to 77°F). The package insert should be consulted for dosage instructions. The medication is available only with a prescription.*
Chemical Structure - dalfampridine str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.